Oregon’s 2023 Legislative Session adjourned on June 25, 2023, wrapping up one of the most dynamic and dramatic sessions in recent history. In January, the session commenced with swearing in
The 2023 Oregon Legislative Session commenced this month with the swearing-in of a new Governor, a new Senate President, and almost 30 new Legislators across both chambers. Oregon Bio is
Shelly Ridder has joined the Oregon Bio team as our Community Engagement and Workforce Manager. She first worked with the Oregon Bioscience Association in 2016 as a BioPro instructor for
A message from Liisa Bozinovic, Oregon Bio Executive Director It is not in the DNA of Oregon’s bioscience industry to rest on its laurels. The unmet needs of patient care
Oregon Bioscience Association released its new economic impact report (posted here) at which points to continued robust growth during the pandemic, with combined economic impacts far outpacing Oregon’s overall economy.
This commentary, “Opinion: How the vaccine has made it all over the world,” authored by Oregon Bio’s 2022 Chair Dan Snyder, recently ran in the Portland Tribune. The barriers to
The Oregon Bioscience Association is pleased to announce that Dr. Akporiaye has joined its Board of Directors Dr. Emmanuel Akporiaye has over 35 years of experience as a cancer researcher.
Travis G. Cook recently met with Oregon Bio to discuss OHSU’s tech transfer initiatives. He’s the senior director of Technology Transfer at Oregon Health & Science University, champions research and
Year in Review with Liisa Bozinovic, Executive Director, Oregon Bioscience Association 2021 was a year of change at the Oregon Bioscience Association for #ORBioMembers as well as the industry on
Regional biotech firms had a record year in VC, as reported by the Portland Business Journal on 1/10/2022. Venture capital poured into the Oregon and Southwest Washington biotech sector in
For this Voice of Industry article, Oregon Bio recently reached out to MSEI and BIOTRONIK, two connected and growing research, development, design and technology companies with North American headquarters in
Oregon Bio recently talked with Erik I. Tucker, Ph.D., president and CEO of Aronora, Inc., a clinical stage biotechnology company developing paradigm-shifting therapies for serious hematologic diseases. Aronora launched and
Oregon Bioscience Association Copyright 2023. All Rights Reserved.